Blood Glucose Management in Intensive Care Units (GINGER)

French Society for Intensive Care

Status: Enrolling

Conditions: Hyperglycemia; Glucose Test Site Bleeding; Insulin Hypoglycemia

Treatments: Drug: Insulin

Study type: Observational

Funder types: Other

Identifiers

NCT05775770

2022-A01304-39

Details and patient eligibility

About

The investigators propose to conduct a study of practices to describe the methods of managing glycemic control in hospitalized patients in critical care. This is a prospective multicenter observational study conducted in Intensive Medicine and Resuscitation departments in France and Belgium. The aim of this study is to carry out an inventory of the current practices of glycemia management as well as their modalities. Being one of the key points of the management, this work will have for main objective to raise the importance of the glycemic variabilities according to the methods of insulin therapies used.

Enrollment: 525 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with hyperglycaemia requiring an insulin prescription within 48 hours of admission
• Insulin therapy started less than 12 hours before inclusion of the patient in the study
• Expected duration of hospitalization greater than or equal to 48 hours

Exclusion criteria

• Moribund patients
• Patients admitted for ketoacidosis or hyperosmolar coma
• Patients admitted for symptomatic hypoglycaemia
• Patient requiring insulin for serum potassium correction
• Severe acute hepatocellular insufficiency
• Age < 18 years old
• Pregnant or breastfeeding women
• Patients under legal protection measures